Opioid trafficking is one of the main sources of income for organised crime in Central Asia. Trafficking perpetuates illicit activities, and encourages corruption, drug abuse and HIV infection, presenting serious implications for the legal, economic and social stability of countries in Central Asia.
The Central Asia Drug Action Programme (CADAP) is a European Union initiative that has been promoting the development of effective drug demand reduction policies, based on evidence and good practices since 2003. The goal is to strengthen the ability of governments of the Central Asian countries to deal with the drug phenomenon in a comprehensive and sustainable manner.
In its seventh phase (2021-2024), led by FIIAPP, CADAP will reduce drug use in Central Asia with a human-rights-based approach, including a gender-conscious perspective, in all actions. It will also work in collaboration with the European Observatory on Drugs and Drug Addiction (EMCDDA) and the Spanish PNSD.
The programme will especially focus on new psychoactive substances, the spread of HIV, care for migrants, prevention of violence and drug use among young people, alternatives to incarceration for drug-related crimes and analysing the impact of the COVID-19 pandemic on the drug market and consumption patterns in the populations of Central Asian countries.
Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan.
Políticas sociales, libertades y derechos
Plan Nacional sobre Drogas (PNSD)
Start - 16/02/2021
End - 16/08/2024